當了爺爺的牙醫陳景祥,兩年前被確診罹患罕見癌症多發性骨髓瘤,當時剛出生的孫女成為生命中最好禮物。陳景祥開刀後積極做復建,幾乎跟著孫女重新學走路。他呼籲大家,不要輕忽腰酸背痛,同時要做血液生化檢查。

癌症希望基金會今天在台北希望小站舉辦「希望」相伴「髓」心所欲—多發性骨髓瘤記者會。

70歲牙醫陳景祥,兩年前騎車摔倒至骨科就醫後,發現骨密度相當差,且長期有貧血症狀,轉診至血液腫瘤科後,被確診罹患多發性骨髓瘤。陳景祥表示,一直以來都維持運動習慣,作息也正常,但血色素偏低,後來抱孫女時感覺到身體疼痛。

陳景祥說,「我學醫的,但以前只聽過這個名詞。」得病後身體狀況很差,動了脊椎手術後,需要靠背架支撐才能站立,穿了半年,流汗時一天要換三件衣服。孫女成了最好的禮物,幾乎是一起學走路、一起學習,支撐自己度過難關。

台大醫院血液腫瘤科醫師黃聖懿表示,多發性骨髓瘤是一種罕見癌症,骨髓裡的漿細胞,即免疫系統中負責產生抗體的重要細胞,癌化後在骨髓中不斷複製增生,形成腫瘤。

黃聖懿指出,多發性骨髓瘤好發在65至70歲的老年族群,男女比近二比一,可說是「老男人的癌症」。有四種典型症狀,骨痛、貧血、尿液泡泡多和高血鈣,這些常和生理性疾病混淆在一起,例如老人家腰酸背痛會先去診所等處看骨科,拖到病情惡化後才就醫詳細檢查。

黃聖懿表示,目前有藥物治療,年輕病友會做造血幹細胞移植,年紀大的病友可藉由標靶藥物組合治療,存活期從過去的兩年半延長至五到七年,甚至有四分之一超過十年,死亡率逐漸下降。因此,鼓勵病友積極治療,正向面對疾病,但較困難的是患者在病情穩定後,如何自我照顧和恢復社會功能。

When the grandfather's dentist Chen Jingxiang was diagnosed with rare cancer multiple myeloma two years ago, the newly born granddaughter became the best gift in life. Chen Jingxiang actively rebuilt after the knife was opened, and almost followed the granddaughter to learn to walk again. He appealed to everyone not to neglect the back pain and to do blood biochemical tests.

The Cancer Hope Foundation held a "Hope" in Taipei's Hope Station today, accompanied by a "myeloid"-multiple myeloma press conference.

Chen Jingxiang, a 70-year-old dentist, who fell to the orthopedics two years ago and found that the bone density was quite poor, and he had symptoms of anemia for a long time. After being referred to the hematology department, he was diagnosed with multiple myeloma. Chen Jingxiang said that he has always maintained his exercise habits and his work routine is normal, but his hemoglobin is low. He later felt his body pain when he was holding his granddaughter.

Chen Jingxiang said, "I have studied medicine, but I have only heard this term before." After getting sick, my physical condition is very poor. After the operation of the spine, I need the support of the backrest to stand. After wearing for half a year, I have to change three pieces a day when I sweat. clothes. Granddaughter has become the best gift, almost learning to walk together, learning together, supporting themselves to tide over the difficulties.

Huang Shengwei, a hematology oncologist at National Taiwan University Hospital, said that multiple myeloma is a rare cancer. Plasma cells in the bone marrow, the important cells responsible for antibody production in the immune system, continue to replicate and proliferate in the bone marrow after canceration, forming tumors.

Huang Shengqi pointed out that multiple myeloma occurs in the elderly population aged 65 to 70. The ratio of male to female is nearly two to one. It can be said to be "an old man's cancer." There are four typical symptoms, bone pain, anemia, urinary bubble and high blood calcium, which are often confused with physiological diseases. For example, the elderly suffer from back pain in the clinic and go to the clinic to see orthopedics. Only go to the doctor for a detailed examination.

Huang Shengqi said that there are currently medical treatments. Young patients will do hematopoietic stem cell transplantation. Older patients can be treated with a combination of target drugs. The survival period has been extended from the past two and a half years to five to seven years, and even one quarter. For more than a decade, the mortality rate has gradually declined. Therefore, patients are encouraged to actively treat and face the disease, but it is more difficult for patients to take care of themselves and restore social function after the condition is stable.

laennec is the ethical drug manufactured with JBP’s unique technologies.

laennec is the ethical drug manufactured with JBP’s unique technologies for effective extraction of variety of growth factors, cytokines, and other physiologically active substances from the human placenta. For instance, HGF (hepatocyte growth factor) promotes the proliferation of hepatic parenchymal cells for recovery of a damaged liver. Our product safety is ensured by the most rigid safety measures among existing scientific standards.

arrow
arrow
    文章標籤
    laennec
    全站熱搜

    oscarglendwgn 發表在 痞客邦 留言(0) 人氣()